As Europe's leading provider of medical imaging services, Alliance Medical is at the forefront of molecular imaging technology.
We deliver high quality PET/CT scanning services to both public and private sector healthcare providers and in partnership with the NHS, we currently carry out the highest number of PET/CT scans in the UK.
We also manufacture and distribute PET radiopharmaceuticals through our network of four radiopharmaceutical production units, giving Alliance Medical a fully integrated supply chain for molecular imaging services.
What is molecular imaging?
Molecular imaging is a type of medical imaging that provides a detailed image or images of what is happening inside the body at the molecular and cellular level. Unlike x-rays and CT scans which offer images of anatomical structure, molecular imaging allows physicians to see how the body is functioning and to measure its chemical and biological processes.
Molecular imaging includes the fields of nuclear medicine and PET which use very small amounts of radioactive materials (radiopharmaceuticals) to diagnose disease. In nuclear medicine imaging, the radiopharmaceuticals are detected by scanners that provide very precise pictures of the area of the body being imaged. The amount of radiation in a typical PET imaging procedure is comparable with that received during a diagnostic x-ray.
AML Quality Account 2020
The report has now been finalised and is ready for download
Leadership
View profiles of our UK Board and Management Team
Our story
Learn more about our history and growth
Governance
Corporate governance and quality assured service excellence
Alliance Medical are Europe’s leading independent provider of medical imaging services.
We combine service excellence and innovative imaging technologies to improve patient care and support NHS and independent sector organisations with their ongoing imaging requirements. Our approach has delivered consistent company growth for more than 25 years.
